According to the suggested guidelines for the interpretation of the AUSROC value [44], serum HER2 had a moderate (0.7 < AUC < 0.9) diagnostic ability to discriminate HER2-positive gastric cancer patients from HER2-negative patients. The gene discussed is ERBB2; the disease is gastric cancer.